AwardTape · Defense awards · Roche Diagnostics S.p.a
Roche Diagnostics S.p.a: $46K in DoD and DHS awards
Roche Diagnostics S.p.a holds 3 DoD and DHS prime awards with $46K obligated Dec 30, 2025 to Apr 14, 2026. Largest category: Diagnostics and lab supplies at $46K; largest buyer: Defense Health Agency at $46K.
| Obligated FY2024+ | $46K |
|---|---|
| Awards | 3 |
| FY2024 | $0 |
| FY2025 | $0 |
| FY2026 to date | $46K |
| Lifetime obligated on these awards | $46K |
| Parent company (as reported) | Roche Diagnostics S.p.a |
| First and latest action | Dec 30, 2025 · Apr 14, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Diagnostics and lab supplies | $46K | 3 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $46K | 3 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT940626FE026 delivery order | $42K | Clinical chemistry cost per reportable result | Defense Health Agency | Diagnostics and lab supplies | Feb 26, 2026 DoD 90d |
| W9114F26FA027 delivery order | $3.4K | Clinical chemistry cost per reportable result | Defense Health Agency | Diagnostics and lab supplies | Apr 14, 2026 DoD 90d |
| W9114F26DA005 IDIQ contract | $0 | Clinical chemistry cost per reportable result | Defense Health Agency | Diagnostics and lab supplies | Apr 13, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 12, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial